Asthma trials in Hungary

In Hungary 16 Also abroad 500

16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Where
Budapest, Budapest III, Debrecen, Eger, Kaposvár, Nagykanizsa, Szigetvar
Age
6 years to 11 years
People
42 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Budapest III, Gödöllő, Nagykanizsa, Szeged, Szigetvar
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Szeged
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Debrecen, Szeged, Szigetvár
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Budapest, Budapest III, Budapest Viii, Gyula, Hajdúnánás, Mosonmagyaróvár, Szigetvar, Szombathely
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Edelény, Gödöllő, Hajdúnánás, Mosonmagyaróvár, Pecs
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Balassagyarmat, Budapest III, Budapest XII, Debrecen, Gödöllő, Pécs, Törökbálint
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
Phase 2Taking people
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Where
Debrecen, Oroshaza, Szeged, Székesfehérvár, Szigetvar
Age
4 years to 11 years
People
69 worldwide
Run by
AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Debrecen, Gödöllő, Mosonmagyaróvár, Pécs, Puspokladany
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Budapest, Debrecen, Székesfehérvár, Szigetvar
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Budapest, Debrecen, Szeged
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
Phase 2Taking people
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Where
Edelény
Age
18 years to 75 years
People
512 worldwide
Run by
Kinaset Therapeutics Inc
See details and how to joinNCT07532265 · EU 2023-509125-41-00
Phase 2Taking people
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Where
Békéscsaba, Budapest III, Budapest XX, Edelény, Hajdúnánás, Hatvan, Monor, Nyiregyhaza, Nyíregyháza, Szeged, Szolnok, Szombathely
Age
18 years to 75 years
People
780 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00
No phaseTaking people
Investigation of the Respiratory Profile of Patients With Obstructive Pulmonary Disease (ASTHMA, COPD)
Where
Budapest, Csorna, Debrecen, Dunakeszi, Győr, Szeged, Törökbálint
Age
18 years and over
People
150
Run by
Tradeflex Ltd
See details and how to joinNCT06966271
No phaseNot yet taking people in Hungary
The Importance of Tailored Education And Device Handling for Asthmatic Patients
Where
Budapest, Csorna, Debrecen, Dunakeszi, Szeged, Törökbálint
Age
18 years and over
People
250
Run by
Chiesi Hungary Ltd.
See details and how to joinNCT06840522
No phaseTaking people
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
Where
Békéscsaba, Budapest, Csorna, Debrecen, Deszk, Dunakeszi, Esztergom, Fehérgyarmat, Gyöngyös, Győr, Gyula, Hajdúböszörmény, Jászberény, Kalocsa, Kaposvár, Keszthely, Kistelek, Kisvárda, Komárom, Kunszentmárton, Marcali, Mátraháza, Mosonmagyaróvár, Nagykanizsa, Nyírbátor, Nyíregyháza, Orosháza, Pásztó, Pécs, Sarkad, Siófok, Szeged, Székesfehérvár, Szolnok, Szombathely, Törökbálint, Zalaegerszeg
Age
18 years and over
People
800
Run by
Chiesi Hungary Ltd.
See details and how to joinNCT06678191